The rate of subjects treated with anti‐osteoporotic therapy was slightly higher in HC patients (31.1%) as compared to NC patients (24.1%), but this difference did not reach statistical significance.
← all excerpts
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.
1
—
—